摘要
目的:观察芪苈强心胶囊对慢性心力衰竭患者血管紧张素Ⅱ的影响,探讨芪苈强心胶囊的作用机制。方法:入选86例慢性心力衰竭患者,随机分为观察组和对照组,均给予ACEI类、利尿剂、卡维地洛或倍他乐克和地戈辛等常规西药治疗,观察组在常规治疗基础上加服芪苈强心胶囊4粒,3次/d。治疗4周后观察两组患者血浆血管紧张素Ⅱ(AngII)水平的变化。结果:①治疗后两组患者血浆血管紧张素Ⅱ水平与治疗前比较均下降(P<0.05),且观察组下降更明显,与对照组比较有显著差异(P<0.05)。②观察组显效率及总有效率均高于对照组(P<0.05)。③两组患者均无不良事件发生。结论:芪苈强心胶囊联合常规西药,可有效地降低心衰患者血浆血管紧张素Ⅱ水平、提高临床疗效,并且无不良反应。
Objective:To investigate the influence of Qiliqiangxin caps on the level of angiotoninII in patient with chronic heart failure and the mechanisem of Qiliqiangxin caps on patient with chronic heart failure.Methods:86 patients with chronic heart failure were selected and divided into control group and observation group randomly.The patienets in control group were given angiotensin-converting enzyme inhibitor,diuretic,carvedilol or metoprolol and dixina and so on.The patienets in observation group were given Qiliqiangxin caps extra.The level of angiotoninII in all patients were detected after therapy 4weeks.Results:①The level of angiotoninII in all patients decreased after therapy 4weeks(P 0.05),while the observation group decreased furthermore(P 0.05).②The total excellent rate and effective rate wre higher of observation group than control group(P 0.05).③There was no harmful events in these groups.Conclusion:Qiliqiangxin caps can decrease the level of angiotoninII and increase the clinic curative effect in patients with chronic heart failure.While there was no harmful events.
出处
《辽宁中医杂志》
CAS
北大核心
2010年第8期1511-1512,共2页
Liaoning Journal of Traditional Chinese Medicine
基金
河北省中医药管理局中医药中西医结合科研计划课题(2008031)